Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 101 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,286,000 | -59.8% | 297,252 | -15.7% | 0.06% | -58.6% |
| Q1 2021 | $10,666,000 | -24.4% | 352,717 | +23.8% | 0.16% | -31.1% |
| Q4 2020 | $14,104,000 | +23.2% | 284,868 | -4.5% | 0.23% | -3.0% |
| Q3 2020 | $11,448,000 | -20.6% | 298,213 | -10.7% | 0.24% | -33.0% |
| Q2 2020 | $14,423,000 | +24.3% | 333,860 | -24.9% | 0.35% | -9.5% |
| Q1 2020 | $11,600,000 | -17.0% | 444,436 | -0.6% | 0.39% | +4.3% |
| Q4 2019 | $13,976,000 | +159.0% | 447,242 | +116.0% | 0.37% | +111.4% |
| Q3 2019 | $5,397,000 | +18.1% | 207,089 | +3.6% | 0.18% | +23.1% |
| Q2 2019 | $4,570,000 | – | 199,843 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |